期刊论文详细信息
FEBS Letters
VIP‐derived sequences modified by N‐terminal stearyl moiety induce cell death: the human keratinocyte as a model
Granoth, Ruth1  Fridkin, Mati2  Gozes, Illana1  Rubinraut, Sara2 
[1] Department of Clinical Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel;Department of Organic Chemistry, The Weizmann Institute of Science, Rehovot 76100, Israel
关键词: Vasoactive intestinal peptide;    Keratinocyte cytotoxicity;    cGMP;    Lipophilic peptide;    Aurine-tricarboxylic acid;    VIP;    vasoactive intestinal peptide;    SNV;    stearyl-Nle17-VIP;    SNH;    stearyl-Nle17-neurotensin6–11VIP7–28;    St-KKYL-NH2;    stearyl-Lys-Lys-Tyr-Leu-NH2;    ATA;    aurine-tricarboxylic acid;    PACAP;    pituitary adenylate cyclase activating peptide;    VHA;    neurotensin6–11VIP7–28;    LDH;    lactate dehydrogenase;    GnRH;    gonadotropin releasing hormone;    CHI;    cycloheximide;    Pr;    propionyl;    K-SFM;    keratinocyte serum free medium;    EGF;    epidermal growth factor;    MEM;    minimal Eagle's essential medium;    FCS;    fetal calf serum;   
DOI  :  10.1016/S0014-5793(00)01629-X
学科分类:生物化学/生物物理
来源: John Wiley & Sons Ltd.
PDF
【 摘 要 】

Vasoactive intestinal peptide (VIP) is a recognized growth factor affecting many cell types. We have previously developed a series of lipophilic VIP analogues containing an N-terminal covalently attached stearyl moiety. The current studies identified stearyl-Nle17-VIP and stearyl-Nle17-neurotensin6–11VIP7–28, acting at μM concentrations, as cytotoxic to human keratinocytes. The core C-terminal active VIP-derived peptide, stearyl-Lys-Lys-Tyr-Leu-NH2 (St-KKYL-NH2), was identified as being responsible for the observed cytotoxicity. Cytotoxicity coincided with marked reduction in intracellular cyclic GMP and was abolished by co-treatment with the endonuclease inhibitor, aurine-tricarboxylic acid, suggesting apoptotic mechanisms. Stearyl-VIP derivatives thus offer lead compounds for future drug development against hyperproliferative skin conditions.

【 授权许可】

Unknown   

【 预 览 】
附件列表
Files Size Format View
RO201912020309448ZK.pdf 358KB PDF download
  文献评价指标  
  下载次数:5次 浏览次数:21次